PLIANT THERAPEUTICS, INC. (PLRX) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pliant Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $9.67 M, a 18.9% decline year-over-year.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $42.2 M, a 36.3% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.5 M, a 96.8% increase from 2022.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.6 M, a 117% increase from 2021.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.4 M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $42.2 M $9.67 M -$2.26 M -18.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $44.5 M $9.15 M -$1.71 M -15.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $46.2 M $10.4 M +$5.56 M +116% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $40.6 M $13 M +$9.64 M +283% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $31 M $11.9 M +$8.39 M +238% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $22.6 M $10.9 M +$8.09 M +292% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $14.5 M $4.81 M +$2 M +71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $12.5 M $3.4 M +$1.12 M +49.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $11.4 M $3.53 M +$953 K +37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.4 M $2.77 M +$1.25 M +82.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $9.18 M $2.81 M +$1.64 M +140% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $7.54 M $2.28 M +$1.49 M +190% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $6.05 M $2.58 M +$2.15 M +507% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $3.9 M $1.52 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.17 M +$689 K +144% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $786 K +$280 K +55.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $425 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $480 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $506 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.